Test Code ACRN Acylcarnitines, Quantitative, Plasma
Additional Codes
Outreach (Atlas) Order Code
ACRN
Hospital (Cerner) Order Code
ACRN
Reporting Name
Acylcarnitines, Quantitative, PUseful For
Diagnosis of fatty acid oxidation disorders and several organic acidurias using plasma specimens
Evaluating treatment during follow-up of patients with fatty acid beta-oxidation disorders and several organic acidurias
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
PlasmaNecessary Information
1. Patient's age is required.
2. Include family history, clinical condition (asymptomatic or acute episode), diet, and drug therapy information.
Specimen Required
Patient Preparation: Collect specimen just prior to a scheduled meal or feeding.
Collection Container/Tube:
Preferred: Green top (sodium heparin)
Acceptable: Lavender top (EDTA) or green top (lithium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.1 mL
Collection Instructions: Centrifuge and aliquot plasma into plastic vial.
Specimen Minimum Volume
0.04 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma | Frozen (preferred) | 92 days | |
Refrigerated | 64 days | ||
Ambient | 8 days |
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82017
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ACRN | Acylcarnitines, Quantitative, P | 43433-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
82413 | Acylcarnitines, Quantitative, P | 46252-3 |
10288 | Acetylcarnitine, C2 | 30191-1 |
36497 | Acrylylcarnitine, C3:1 | 43235-1 |
10289 | Propionylcarnitine, C3 | 30551-6 |
36498 | Formiminoglutamate, FIGLU | 79628-4 |
10290 | Iso-/Butyrylcarnitine, C4 | 43243-5 |
36499 | Tiglylcarnitine, C5:1 | 51416-6 |
10293 | Isovaleryl-/2-Methylbutyrylcarn C5 | 30531-8 |
36500 | 3-OH-iso-/butyrylcarnitine, C4-OH | 39000-5 |
36501 | Hexenoylcarnitine, C6:1 | 74540-6 |
10295 | Hexanoylcarnitine, C6 | 30358-6 |
36502 | 3-OH-isovalerylcarnitine, C5-OH | 39001-3 |
36503 | Benzoylcarnitine | 39615-0 |
36504 | Heptanoylcarnitine, C7 | 55871-8 |
10297 | 3-OH-hexanoylcarnitine, C6-OH | 30236-4 |
36505 | Phenylacetylcarnitine | 90237-9 |
36506 | Salicylcarnitine | 90238-7 |
10298 | Octenoylcarnitine, C8:1 | 30541-7 |
10299 | Octanoylcarnitine, C8 | 30540-9 |
36507 | Malonylcarnitine, C3-DC | 55940-1 |
36508 | Decadienoylcarnitine, C10:2 | 53471-9 |
10301 | Decenoylcarnitine, C10:1 | 30328-9 |
10302 | Decanoylcarnitine, C10 | 30327-1 |
36509 | Methylmalonyl-/succinylcarn, C4-DC | 51415-8 |
36510 | 3-OH-decenoylcarnitine, C10:1-OH | 82478-9 |
10304 | Glutarylcarnitine, C5-DC | 30349-5 |
10305 | Dodecenoylcarnitine, C12:1 | 30332-1 |
10306 | Dodecanoylcarnitine, C12 | 30331-3 |
36511 | 3-Methylglutarylcarnitine, C6-DC | 39002-1 |
36512 | 3-OH-dodecenoylcarnitine, C12:1-OH | 59195-8 |
10307 | 3-OH-dodecanoylcarnitine, C12-OH | 30233-1 |
10308 | Tetradecadienoylcarnitine, C14:2 | 30564-9 |
10309 | Tetradecenoylcarnitine, C14:1 | 30566-4 |
10310 | Tetradecanoylcarnitine, C14 | 30565-6 |
36513 | Octanedioylcarnitine, C8-DC | 39014-6 |
10311 | 3-OH-tetradecenoylcarnitine C14:1OH | 30190-3 |
10312 | 3-OH-tetradecanoylcarnitine, C14-OH | 30238-0 |
10313 | Hexadecenoylcarnitine, C16:1 | 30357-8 |
10314 | Hexadecanoylcarnitine, C16 | 30356-0 |
10315 | 3-OH-hexadecenoylcarnitine,C16:1-OH | 30235-6 |
10316 | 3-OH-hexadecanoylcarnitine, C16-OH | 30234-9 |
10317 | Octadecadienoylcarnitine, C18:2 | 30534-2 |
10318 | Octadecenoylcarnitine, C18:1 | 30542-5 |
10319 | Octadecanoylcarnitine, C18 | 30560-7 |
36514 | Dodecanedioylcarnitine, C12-DC | 55855-1 |
10320 | 3-OH-octadecadienoylcarn, C18:2-OH | 30237-2 |
10321 | 3-OH-octadecenoylcarnitine C18:1-OH | 30312-3 |
36515 | 3-OH-octadecanoylcarnitine, C18-OH | 35656-8 |
10322 | Comment (ACRN) | 48767-8 |
Report Available
2 to 5 daysReject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Method Name
Flow Injection Analysis-Tandem Mass Spectrometry (FIA-MS/MS)
Reference Values
≤7 days (nmol/mL) |
8 days-7 years (nmol/mL) |
≥8 years (nmol/mL) |
|
Acetylcarnitine, C2 |
2.14-15.89 |
2.00-27.57 |
2.00-17.83 |
Acrylylcarnitine, C3:1 |
<0.04 |
<0.05 |
<0.07 |
Propionylcarnitine, C3 |
<0.55 |
<1.78 |
<0.88 |
Formiminoglutamate, FIGLU |
<0.43 |
<0.08 |
<0.14 |
Iso-/Butyrylcarnitine, C4 |
<0.46 |
<1.06 |
<0.83 |
Tiglylcarnitine, C5:1 |
<0.05 |
<0.09 |
<0.11 |
Isovaleryl-/2-Methylbutyrylcarn C5 |
<0.38 |
<0.63 |
<0.51 |
3-OH-iso-/butyrylcarnitine, C4-OH |
<0.13 |
<0.51 |
<0.18 |
Hexenoylcarnitine, C6:1 |
<0.12 |
<0.10 |
<0.15 |
Hexanoylcarnitine, C6 |
<0.14 |
<0.23 |
<0.17 |
3-OH-isovalerylcarnitine, C5-OH |
<0.08 |
<0.12 |
<0.10 |
Benzoylcarnitine |
<0.13 |
<0.07 |
<0.10 |
Heptanoylcarnitine, C7 |
<0.05 |
<0.05 |
<0.06 |
3-OH-hexanoylcarnitine, C6-OH |
<0.08 |
<0.19 |
<0.09 |
Phenylacetylcarnitine |
<0.15 |
<0.22 |
<0.29 |
Salicylcarnitine |
<0.08 |
<0.09 |
<0.09 |
Octenoylcarnitine, C8:1 |
<0.48 |
<0.91 |
<0.88 |
Octanoylcarnitine, C8 |
<0.19 |
<0.45 |
<0.78 |
Malonylcarnitine, C3-DC |
<0.09 |
<0.14 |
<0.26 |
Decadienoylcarnitine, C10:2 |
<0.11 |
<0.12 |
<0.26 |
Decenoylcarnitine, C10:1 |
<0.25 |
<0.46 |
<0.47 |
Decanoylcarnitine, C10 |
<0.27 |
<0.91 |
<0.88 |
Methylmalonyl-/succinylcarn, C4-DC |
<0.05 |
<0.05 |
<0.05 |
3-OH-decenoylcarnitine, C10:1-OH |
<0.12 |
<0.12 |
<0.13 |
Glutarylcarnitine, C5-DC |
<0.06 |
<0.10 |
<0.11 |
Dodecenoylcarnitine, C12:1 |
<0.19 |
<0.37 |
<0.35 |
Dodecanoylcarnitine, C12 |
<0.18 |
<0.35 |
<0.26 |
3-Methylglutarylcarnitine, C6-DC |
<0.28 |
<0.21 |
<0.43 |
3-OH-dodecenoylcarnitine, C12:1-OH |
<0.11 |
<0.10 |
<0.13 |
3-OH-dodecanoylcarnitine, C12-OH |
<0.06 |
<0.09 |
<0.08 |
Tetradecadienoylcarnitine, C14:2 |
<0.09 |
<0.13 |
<0.18 |
Tetradecenoylcarnitine, C14:1 |
<0.16 |
<0.35 |
<0.24 |
Tetradecanoylcarnitine, C14 |
<0.11 |
<0.15 |
<0.12 |
Octanedioylcarnitine, C8-DC |
<0.25 |
<0.19 |
<0.19 |
3-OH-tetradecenoylcarnitine C14:1OH |
<0.06 |
<0.18 |
<0.13 |
3-OH-tetradecanoylcarnitine, C14-OH |
<0.04 |
<0.05 |
<0.08 |
Hexadecenoylcarnitine, C16:1 |
<0.15 |
<0.21 |
<0.10 |
Hexadecanoylcarnitine, C16 |
<0.36 |
<0.52 |
<0.23 |
3-OH-hexadecenoylcarnitine,C16:1-OH |
<0.78 |
<0.36 |
<0.06 |
3-OH-hexadecanoylcarnitine, C16-OH |
<0.10 |
<0.07 |
<0.06 |
Octadecadienoylcarnitine, C18:2 |
<0.12 |
<0.31 |
<0.24 |
Octadecenoylcarnitine, C18:1 |
<0.25 |
<0.45 |
<0.39 |
Octadecanoylcarnitine, C18 |
<0.10 |
<0.12 |
<0.14 |
Dodecanedioylcarnitine, C12-DC |
<0.10 |
<0.04 |
<0.04 |
3-OH-octadecadienoylcarn, C18:2-OH |
<0.04 |
<0.06 |
<0.06 |
3-OH-octadecenoylcarnitine C18:1-OH |
<0.03 |
<0.04 |
<0.06 |
3-OH-octadecanoylcarnitine, C18-OH |
<0.03 |
<0.05 |
<0.03 |
Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.